196 related articles for article (PubMed ID: 28386106)
1. Myeloproliferative leukemia protein activation directly induces fibrocyte differentiation to cause myelofibrosis.
Maekawa T; Osawa Y; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Saga R; Kato S; Yamamura T; Watanabe J; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Kimura F
Leukemia; 2017 Dec; 31(12):2709-2716. PubMed ID: 28386106
[TBL] [Abstract][Full Text] [Related]
2. [The role of fibrocytes in myelofibrosis and fibrocyte regulation as a novel treatment approach].
Maekawa T; Kato S; Kimura F
Rinsho Ketsueki; 2020; 61(1):3-10. PubMed ID: 32023599
[TBL] [Abstract][Full Text] [Related]
3. A thrombopoietin receptor antagonist is capable of depleting myelofibrosis hematopoietic stem and progenitor cells.
Wang X; Haylock D; Hu CS; Kowalczyk W; Jiang T; Qiu J; Mosoyan G; He W; Marshall N; Mascarenhas J; Tarasova A; Brody J; Winkler D; Hoffman R
Blood; 2016 Jun; 127(26):3398-409. PubMed ID: 27114459
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin and hematopoietic stem cells.
de Graaf CA; Metcalf D
Cell Cycle; 2011 May; 10(10):1582-9. PubMed ID: 21478671
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of ALK5 inhibition in myelofibrosis.
Yue L; Bartenstein M; Zhao W; Ho WT; Han Y; Murdun C; Mailloux AW; Zhang L; Wang X; Budhathoki A; Pradhan K; Rapaport F; Wang H; Shao Z; Ren X; Steidl U; Levine RL; Zhao ZJ; Verma A; Epling-Burnette PK
JCI Insight; 2017 Apr; 2(7):e90932. PubMed ID: 28405618
[TBL] [Abstract][Full Text] [Related]
6. Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.
Marty C; Pecquet C; Nivarthi H; El-Khoury M; Chachoua I; Tulliez M; Villeval JL; Raslova H; Kralovics R; Constantinescu SN; Plo I; Vainchenker W
Blood; 2016 Mar; 127(10):1317-24. PubMed ID: 26608331
[TBL] [Abstract][Full Text] [Related]
7. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
[TBL] [Abstract][Full Text] [Related]
8. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
[TBL] [Abstract][Full Text] [Related]
9. Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow.
Wang JC; Hashmi G
Leuk Res; 2003 Jan; 27(1):13-7. PubMed ID: 12479847
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of an alternative splice variant of Mpl with a high affinity for TPO and its activation of ERK1/2 signaling.
Wang Q; Sun R; Wu L; Huang J; Wang P; Yuan H; Qiu F; Xu X; Wu D; Yu Y; Liu X; Zhang Q
Int J Biochem Cell Biol; 2013 Dec; 45(12):2852-63. PubMed ID: 24144576
[TBL] [Abstract][Full Text] [Related]
11. Increased SLAMF7
Maekawa T; Kato S; Kawamura T; Takada K; Sone T; Ogata H; Saito K; Izumi T; Nagao S; Takano K; Okada Y; Tachi N; Teramoto M; Horiuchi T; Hikota-Saga R; Endo-Umeda K; Uno S; Osawa Y; Kobayashi A; Kobayashi S; Sato K; Hashimoto M; Suzu S; Usuki K; Morishita S; Araki M; Makishima M; Komatsu N; Kimura F
Blood; 2019 Sep; 134(10):814-825. PubMed ID: 31270105
[TBL] [Abstract][Full Text] [Related]
12. C-Mannosylation of thrombopoietin receptor (c-Mpl) regulates thrombopoietin-dependent JAK-STAT signaling.
Sasazawa Y; Sato N; Suzuki T; Dohmae N; Simizu S
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):262-8. PubMed ID: 26505790
[TBL] [Abstract][Full Text] [Related]
13. The thrombopoietin/MPL axis is activated in the Gata1
Zingariello M; Sancillo L; Martelli F; Ciaffoni F; Marra M; Varricchio L; Rana RA; Zhao C; Crispino JD; Migliaccio AR
Blood Cancer J; 2017 Jun; 7(6):e572. PubMed ID: 28622305
[TBL] [Abstract][Full Text] [Related]
14. Deciphering the differential impact of thrombopoietin/MPL signaling on hematopoietic stem/progenitor cell function in bone marrow and spleen.
Lee S; Zhan H
Stem Cell Reports; 2024 Feb; 19(2):211-223. PubMed ID: 38215758
[TBL] [Abstract][Full Text] [Related]
15. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.
Zhang Y; Lin CHS; Kaushansky K; Zhan H
Stem Cells; 2018 Nov; 36(11):1676-1684. PubMed ID: 30005133
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin induces hematopoiesis from mouse ES cells via HIF-1α-dependent activation of a BMP4 autoregulatory loop.
Pramono A; Zahabi A; Morishima T; Lan D; Welte K; Skokowa J
Ann N Y Acad Sci; 2016 Jul; 1375(1):38-51. PubMed ID: 27447537
[TBL] [Abstract][Full Text] [Related]
18. A preliminary investigation into the action of anagrelide: thrombopoietin-c-Mpl receptor interactions.
McCarty JM; Melone PD; Simanis JP; Kanamori D; Dessypris EN; Warshamana-Greene GS
Exp Hematol; 2006 Jan; 34(1):87-96. PubMed ID: 16413395
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
20. Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis.
Chaligné R; James C; Tonetti C; Besancenot R; Le Couédic JP; Fava F; Mazurier F; Godin I; Maloum K; Larbret F; Lécluse Y; Vainchenker W; Giraudier S
Blood; 2007 Nov; 110(10):3735-43. PubMed ID: 17709604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]